RPRX – royalty pharma plc - class a ordinary shares (US:NASDAQ)

News

Royalty Pharma Declares Second Quarter 2026 Dividend [Yahoo! Finance]
Royalty Pharma Declares Second Quarter 2026 Dividend
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
Royalty Pharma (RPRX) was given a new $63.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.
Assessing Royalty Pharma (RPRX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com